Uri Elia et al (2021) Design of SARS-CoV2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered via Lipid Nanoparticles. ACS Nano. PDF
Here we present the design of mRNA vaccine based on lipid Nano particles (LNPs)- encapsulated SARS-CoV-2 human Fc-conjugated receptor domain. The data demonstrated the potential of our lipids as promising candidates for LNPs-based ,RNA vaccines in general and for COVID-19 in particular.